Professional Documents
Culture Documents
Epididymitis
Stephanie N. Taylor
Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans
In April 2013, the Centers for Disease Control and Prevention (CDC) convened an advisory group to assist in
development of the 2015 CDC sexually transmitted diseases (STDs) treatment guidelines. The advisory group
examined recent abstracts and published literature addressing the diagnosis and management of sexually trans-
mitted infections. This article summarizes the key questions, evidence, and recommendations for the diagnosis
and management of epididymitis that were considered in preparation of the 2015 CDC STD treatment
guidelines.
Keywords. epididymitis; urethritis; gonorrhea; chlamydia; scrotal pain.
Epididymitis is inflammation of the epididymis due to that were considered in development of the 2015 Cen-
infectious and noninfectious etiologies. When the testicle ters for Disease Control and Prevention sexually trans-
is also involved, it is referred to as epididymo-orchitis. mitted diseases (STDs) treatment guidelines.
Unfortunately, the true prevalence of epididymitis is
unknown. The most current published data report that
there are approximately 600 000 cases of epididymitis METHODS
per year in the United States [1]. Epididymitis accounted
Multiple PubMed database searches for articles about
for 1 in 144 outpatient visits (0.69%) made by men aged
epididymitis were conducted using the Medical Sub-
18–50 years in 2002 [1], and Nickel et al demonstrated
ject Heading “epididymitis,” including all documents
that 1% of men presenting to Canadian outpatient urol-
and subheadings. Searches were limited to English-
ogists had epididymitis [2]. In an article that examined
language articles published from December 2008 to
single and multiple health insurance claims for the di-
December 2012. The search generated 232 abstracts,
agnosis of epididymitis/orchitis in the United States be-
with 11 selected for more detailed review. These abstracts
tween 2001 and 2004, Bohm et al reported that 4636 of
were chosen for complete review and presentation at
316 418 males (1.5%) aged 14–35 years had at least 1
the meeting because the findings and/or conclusions
claim for epididymitis over that period [3]. It was also
answered the key questions put forth by the advisory
noted that 40.6% of the men resided in the southern
committee. The evidence presented in these articles
region of the United States, and a correlation between
also provided the basis for the committee treatment
epididymitis and high rates of sexually transmitted in-
recommendations.
fections in the south was observed. A bimodal distribu-
National conference final program abstract publica-
tion has also been noted, with a peak incidence in men
tions were also searched online including the Infectious
16–30 years of age and those 51–70 years of age [4].
Diseases Society of America 2008–2012 annual meet-
This article summarizes the key questions and evidence
ings (http://www.idsa.confex.com/idsa/archives.cgi);
related to diagnosis and management of epididymitis
the Interscience Conference on Antimicrobial Agents
and Chemotherapy (http://www.icaac.org/); the Inter-
Correspondence: Stephanie N. Taylor, MD, Section of Infectious Diseases, Lou- national Society for Sexually Transmitted Diseases Re-
isiana State University Health Sciences Center, 3308 Tulane Ave, New Orleans, LA
70119 (staylo2@lsuhsc.edu).
search 2009 and 2011 meetings (http://www.isstdr.org/
Clinical Infectious Diseases® 2015;61(S8):S770–3 previous-meetings.php); the American Urological As-
© The Author 2015. Published by Oxford University Press on behalf of the Infectious sociation 2009–2012 annual meetings (http://www.
Diseases Society of America. All rights reserved. For Permissions, please e-mail:
journals.permissions@oup.com.
aua2012.org/abstracts/abstracts.cfm); and the National
DOI: 10.1093/cid/civ812 STD Prevention Conference 2004, 2006, and 2008